GAREV Medical, LLC is a privately-held life sciences company focused on the development of technologies and methodologies that help individuals to manage their health more effectively and efficiently.  The company has four clinical areas of focus:

Diabetes / Obesity

• Type 1 Diabetes - Affecting over 23 million people worldwide
• Type 2 Diabetes - Affecting over 230 million people worldwide
• Obesity - Affecting over 300 million people worldwide

Asthma

• Affecting over 300 million people worldwide

Dupuytrens Disease

• Affecting up to 5% of the adult population worldwide

Topographical Fungal Infections

•  Affecting up to 15% of individuals over the age of 15 worldwide

Our goal is the development of technologies and methods that allow individuals to better manage their health in these focus areas; thereby yielding better long-term outcomes.